Novel Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Race

Fran E Cook-Bolden; Neal Bhatia; Jonathan S Weiss; Neil Sadick; Stephen K Tyring; Eric Guenin; Anya Loncaric; Susan Harris

doi:10.25251/skin.4.supp.88

Fran E Cook-Bolden

Fran E. Cook-Bolden, MD, PLLC and Department of Dermatology, Mount Sinai Hospital Center, New York, NY

Neal Bhatia

Therapeutics Clinical Research, San Diego, CA

Jonathan S Weiss

Georgia Dermatology Partners, and Gwinnett Clinical Research Center, Inc., Snellville, GA

Neil Sadick

Department of Dermatology, Weill Cornell Medical College, New York, NY and Sadick Dermatology, New York, NY

Stephen K Tyring

University of Texas Health Science Center, Houston, TX

Eric Guenin

Ortho Dermatologics, Bridgewater, NJ

Anya Loncaric

Bausch Health US, LLC, Petaluma, CA

Susan Harris

Bausch Health US, LLC, Bridgewater, NJ

Keywords

Acne Vulgaris, Retinoid, Lotion

Abstract

Abstract not available.

References

1. Alexis AF. J Drugs Dermatol. 2014;13(6):s6-s10.

2. Leyden J, et al. Dermatol Ther (Heidelb). 2017;7(3):293-304.

3. Del Rosso JQ and Tanghetti E. J Drugs Dermatol. 2013;12(3)s53-58.

4. Tanghetti EA, et al. J Drugs Dermatol. 2019;18(6):542

5. Tanghetti EA, et al. J Drugs Dermatol. 2020;19(1)70-77.

6. Tanghetti EA, et al. J Drugs Dermatol. 2020;19(3)272-279.

Poster PDF

Published

Oct 27, 2020

DOI https://doi.org/10.25251/skin.4.supp.88

How to Cite

Cook-Bolden, F. E., Bhatia, N., Weiss, J. S., Sadick, N., Tyring, S. K., Guenin, E., Loncaric, A., & Harris, S. (2020). Novel Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Race. SKIN The Journal of Cutaneous Medicine, 4(6), s88. https://doi.org/10.25251/skin.4.supp.88

Issue

Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®)

Section

Acne & Rosacea

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by the following user license:

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

Neal Bhatia, Dermatology and Virtual Realities with Industry: “It’s Not Your Father’s Pharma Anymore” , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 4 (2020)
Michael Vecchiolla, Neal Bhatia, Patient Perspectives on use of a water-based Calcipotriene and Betamethasone Dipropionate Cream for the treatment of Plaque Psoriasis , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference®
Lina Stein Gold, Mark G Lebwohl, Neal Bhatia, Tina Lin, Radhakrishnan Pillai, Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion , SKIN The Journal of Cutaneous Medicine: Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas
Leon Kircik, Zoe D Draelos, Eric Guenin, Tazarotene 0.045% Lotion for Truncal Acne: Efficacy, Tolerability, and Spreadability , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®
Neal Bhatia, Measuring the Predictive Value of Serological Quantification of Cytokines with the Onset of Influenza-Like Signs and Symptoms Induced by Imiquimod 3.75% Cream: Results of a Single Center, Open-Label, Proof of Concept Trial , SKIN The Journal of Cutaneous Medicine: Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas
Neal Bhatia, MD, Jon Kantor, MD, Lawrence Green, MD, Jonathon Weiss, MD, Cynthia Wilson, RN, BSN, Susan Cutler, DMD, Jayson Rieger, PhD, MBA, David K. Glover, ME, PhD, Pamela Rumney, RN, CCRC, Gary Goldenberg, MD, Clinical and Histological Clearance of VP-315: Exploratory Results of an Investigational Non-surgical Immunotherapy in Subjects with Biopsy Proven Basal Cell Carcinoma , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 6 (2023): November 2023 Issue
Neal Bhatia, Andrew Blauvelt, Edward Lain, Abel Jarell, Janet DuBois, Maria Luisa Tamarit, Meritxell Falqués, Vera Kiyasova, Laura Padullés, Raquel Otero, Safety, Tolerability and Efficacy of Tirbanibulin Ointment 1% Treatment on 100 cm2 of the Face and Scalp in Patients with Actinic Keratosis: A Phase 3 Study , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 6 (2023): November 2023 Issue
Heather C Woolery-Lloyd, Julie C Harper, Eric Guenin, Acne-Related Quality of Life: Correlation Between Acne Symptom Scores and Other Domains Following Treatment with Tretinoin 0.05% Lotion , SKIN The Journal of Cutaneous Medicine: Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas
Jayme Heim, J Gabriel Vasquez, Brad Schenkel, Neal Bhatia, Patients’ quality of life in a Phase 4 real-world study of tildrakizumab in moderate-to-severe plaque psoriasis , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference®
Fran E Cook-Bolden, Susan H Weinkle, Eric Guenin, Varsha Blatt, Novel Tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris in a Hispanic population , SKIN The Journal of Cutaneous Medicine: Vol. 2 (2018): Supplemental Issue: Scientific Posters & Abstracts Presented at 2018 Fall Clinical Dermatology Conference®-Las Vegas

<< < 2 3 4 5 6 7 8 > >>

Main Article Content

Keywords

Abstract

References

Article Sidebar

Article Details

Most read articles by the same author(s)